The Filing Desk

Anteris Technologies Global vs Co-Diagnostics

Anteris Technologies Global AVR · Co-Diagnostics CODX · Health Care Equipment

Anteris Technologies Global reported revenue of $2 million in fiscal 2025, 3.2 times Co-Diagnostics' $1 million in fiscal 2025. Anteris Technologies Global's revenue fell 29.2% in its latest year, and Co-Diagnostics' fell 84.1%. Anteris Technologies Global had an operating margin of -4908.2%, against -8058.8% at Co-Diagnostics. Free cash flow was −$80 million at Anteris Technologies Global and −$30 million at Co-Diagnostics.

Side by side

Anteris Technologies GlobalCo-Diagnostics
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$2M$1M
Revenue growth−29.2%−84.1%
Revenue growth a year, last 5 years—−61.9%
Gross margin70.3%64.3%
Operating margin−4,908.2%−8,058.8%
Net margin−4,921.3%−7,533.6%
Free cash flow−$80M−$30M
Free cash flow margin−4,169.2%−4,793.2%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count82.2%31.6%
Last close$5.09$0.16
P/E at the last close——
Insider trades, last 12 monthsbought $28.9 million, sold $25.2 million—
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Anteris Technologies GlobalCo-Diagnostics
Operating margin
Percent of revenue
Anteris Technologies GlobalCo-Diagnostics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Anteris Technologies GlobalCo-Diagnostics

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Anteris Technologies Global and Co-Diagnostics pages.